Prediction of Tumor Response to Neoadjuvant Therapy in Patients with Esophageal Cancer with Use of 18F FDG PET: A Systematic Review

被引:133
作者
Kwee, Robert M. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Radiol & Nucl Med, NL-6202 AZ Maastricht, Netherlands
关键词
POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; ESOPHAGOGASTRIC JUNCTION; PATHOLOGICAL RESPONSE; PREOPERATIVE CHEMORADIATION; METABOLIC-ACTIVITY; INDUCTION CHEMORADIATION; COMPUTED-TOMOGRAPHY; FREE SURVIVAL;
D O I
10.1148/radiol.09091324
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To systematically review the accuracy of fluorine 18 ((18) F) fluorodeoxyglucose (FDG) positron emission tomography (PET) in the prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer. Materials and Methods: The MEDLINE and EMBASE databases were systematically searched for relevant studies. Methodologic quality of the included studies was assessed. Sensitivities and specificities of F-18 FDG PET in individual studies were calculated and underwent meta-analysis with a random effects model. A summary receiver operating characteristic curve (sROC) was constructed with the Moses-Shapiro-Littenberg method. A chi(2) test was performed to test for heterogeneity (defined as P < .10). Potential sources for heterogeneity were explored by assessing whether certain covariates significantly (P < .05) influenced the relative diagnostic odds ratio. Results: Twenty reports, comprising a total of 849 patients with esophageal cancer, were included. Overall, the studies were of moderate methodologic quality. Sensitivity and specificity of F-18 FDG PET ranged from 33% to 100% and from 30% to 100%, respectively, with pooled estimates of 67% (95% confi dence interval: 62%, 72%) and 68% ( 95% confi dence interval: 64%, 73%), respectively. The area under the sROC curve was 0.7815. There was significant heterogeneity in both the sensitivity and specificity of the included studies (P < .0001). Spearman rho between the logit of sensitivity and the logit of 1-specificity was 0.086 (P = .719), which suggested that there was no threshold effect. Studies performed outside of the United States and studies of higher methodologic quality yielded significantly higher overall accuracy. Conclusion: On the basis of current evidence, 18 F FDG PET should not yet be used in routine clinical practice to guide neoadjuvant therapy decisions in patients with esophageal cancer. (C) RSNA, 2010
引用
收藏
页码:707 / 717
页数:11
相关论文
共 50 条
[21]   Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis [J].
Kroese, T. E. ;
Goense, L. ;
van Hillegersberg, R. ;
de Keizer, B. ;
Mook, S. ;
Ruurda, J. P. ;
van Rossum, P. S. N. .
DISEASES OF THE ESOPHAGUS, 2018, 31 (12)
[22]   A Systematic Review of the Predictive Value of 18FDG-PET in Esophageal and Esophagogastric Junction Cancer After Neoadjuvant Chemoradiation on the Survival Outcome Stratification [J].
Schollaert, Pascaline ;
Crott, Ralph ;
Bertrand, Claude ;
D'Hondt, Lionel ;
Vander Borght, Thierry ;
Krug, Bruno .
JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (05) :894-905
[23]   18F-FDG-PET/CT in assessing response to neoadjuvant chemoradiotherapy for potentially resectable locally advanced esophageal cancer [J].
Metser, Ur ;
Rashidi, Farid ;
Moshonov, Hadas ;
Wong, Rebecca ;
Knox, Jennifer ;
Guindi, Maha ;
Darling, Gail .
ANNALS OF NUCLEAR MEDICINE, 2014, 28 (04) :295-303
[24]   Diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in preoperative staging of locoregional urinary bladder cancer: a systematic review and Meta-Analysis [J].
Abdlkadir, Ahmed Saad ;
Al-Adhami, Dhuha ;
Allouzi, Sudqi ;
Badarneh, Mohannad ;
Shahait, Mohammed ;
Abdulrahman, Marwa ;
Ruzzeh, Saad ;
Moghrabi, Serin ;
Al-Ibraheem, Akram .
DISCOVER ONCOLOGY, 2025, 16 (01)
[25]   [18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review [J].
van Uden, D. J. P. ;
Prins, M. W. ;
Siesling, S. ;
de Wilt, J. H. W. ;
Blanken-Peeters, C. F. J. M. ;
Aarntzen, E. H. J. G. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 151
[26]   18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients [J].
Cervino, Anna R. ;
Pomerri, Fabio ;
Alfieri, Rita ;
Sileni, Vanna C. ;
Castoro, Carlo ;
Galuppo, Sara ;
Evangelista, Laura .
NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (02) :160-168
[27]   The role of FDG PET/CT radiomics in the prediction of pathological response to neoadjuvant treatment in patients with esophageal cancer [J].
Eifer, Michal ;
Peters-Founshtein, Gregory ;
Yoel, Lotem Cohn ;
Pinian, Hodaya ;
Steiner, Roee ;
Klang, Eyal ;
Catalano, Onofrio A. ;
Eshet, Yael ;
Domachevsky, Liran .
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2024, 29 (02) :211-218
[28]   Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [18F]FDG PET/CT scans in locally advanced rectal cancer [J].
Bang, Ji-In ;
Ha, Seunggyun ;
Kang, Sung-Bum ;
Lee, Keun-Wook ;
Lee, Hye-Seung ;
Kim, Jae-Sung ;
Oh, Heung-Kwon ;
Lee, Ho-Young ;
Kim, Sang Eun .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (03) :422-431
[29]   Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy [J].
Tandberg, Daniel J. ;
Cui, Yunfeng ;
Rushing, Christel N. ;
Hong, Julian C. ;
Ackerson, Bradley G. ;
Marin, Daniele ;
Zhang, Xuenfeng ;
Czito, Brian G. ;
Willett, Christopher W. ;
Palta, Manisha .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (04) :1002-1007
[30]   Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis [J].
Han, Sangwon ;
Choi, Joon Young .
BREAST CANCER RESEARCH, 2020, 22 (01)